Rapid & Low-Cost DPYD Genotyping to Guide Fluoropyrimidine Treatment in Cancer Patients. Precision Medicine Communications, [S. l.], v. 3, n. 2, p. 83–86, 2023. DOI: 10.55627/pmc.003.02.0485. Disponível em: https://rootspress.org/journals/PMC/article/view/485. Acesso em: 3 apr. 2026.